prikaz prve stranice dokumenta The place of the botulinum toxin in the management of multiple sclerosis
  Preuzmi
PDF 143.92 KB
Znanstveni rad - Pregledni rad
The place of the botulinum toxin in the management of multiple sclerosis
Clinical Neurology and Neurosurgery, 112 (2010), 7; 592-596. https://doi.org/10.1016/j.clineuro.2010.04.010
Habek, Mario; Karni, Arnon; Balash, Yakov; Gurevich, Tanya

Institucijski repozitorij: Dr Med - digitalni repozitorij Medicinskog fakulteta Sveučilišta u Zagrebu

Citirajte ovaj rad

Habek, M., Karni, A., Balash, Y. i Gurevich, T. (2010). The place of the botulinum toxin in the management of multiple sclerosis. Clinical Neurology and Neurosurgery, 112. (7), 592-596. doi: 10.1016/j.clineuro.2010.04.010

Habek, Mario, et al. "The place of the botulinum toxin in the management of multiple sclerosis." Clinical Neurology and Neurosurgery, vol. 112, br. 7, 2010, str. 592-596. https://doi.org/10.1016/j.clineuro.2010.04.010

Habek, Mario, Arnon Karni, Yakov Balash i Tanya Gurevich. "The place of the botulinum toxin in the management of multiple sclerosis." Clinical Neurology and Neurosurgery 112, br. 7 (2010): 592-596. https://doi.org/10.1016/j.clineuro.2010.04.010

Habek, M., et al. (2010) 'The place of the botulinum toxin in the management of multiple sclerosis', Clinical Neurology and Neurosurgery, 112(7), str. 592-596. doi: 10.1016/j.clineuro.2010.04.010

Habek M, Karni A, Balash Y, Gurevich T. The place of the botulinum toxin in the management of multiple sclerosis. Clinical Neurology and Neurosurgery [Internet]. 09.2010. [pristupljeno 30.04.2024.];112(7):592-596. doi: 10.1016/j.clineuro.2010.04.010

M. Habek, A. Karni, Y. Balash i T. Gurevich, "The place of the botulinum toxin in the management of multiple sclerosis", Clinical Neurology and Neurosurgery, vol. 112, br. 7, str. 592-596, Rujan 2010. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:327287. [Citirano: 30.04.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:327287
Podaci o radu
Naslov (engleski)The place of the botulinum toxin in the management of multiple sclerosis
AutorMario Habek
AutorArnon Karni
AutorYakov Balash
AutorTanya Gurevich
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Sažetak (engleski)
Multiple sclerosis (MS) is the most common disabling chronic disease of the central nervous system among young adults. These patients suffer from variety of symptoms that have a profound affect on their working ability, activities of daily living and general quality of life. Treatment of these symptoms is important in order to relief them and improve daily function and quality of life. Many of these symptoms are often resistant to treatment. Botulinum toxin A (BTX) is mainly used for spasticity and bladder dysfunction in MS. It is an effective treatment option for spasticity of the thigh adductor, pes equinus, striatal toe or adductor of the shoulder joint. BTX injections are effective in reducing incontinence episodes and urinary urgency, daytime frequency and nocturia, as well as sustained improvements in quality of life of MS patients with detrusor overreactivity. In addition, BTX is potentially effective in treating pain, trigeminal neuralgia, tremor, neuro-ophthalmologic complications, facial myokymia, gastroparesis, sialorrhea, and hyperhidrosis, however no studies have confirmed its efficacy in MS patients.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pregledni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeZavršna verzija rukopisa prihvaćena za objavljivanje (postprint)
Naslov časopisaClinical Neurology and Neurosurgery
Brojčani podacivol. 112, br. 7, str. 592-596
p-ISSN0303-8467
DOIhttps://doi.org/10.1016/j.clineuro.2010.04.010
URN:NBNurn:nbn:hr:105:327287
Datum objave publikacije2010-09
URL dokumentahttps://doi.org/10.1016/j.clineuro.2010.04.010
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2024-03-28 11:56:48